Cannabidiol for the Treatment of Anxiety Disorders: An 8-Week Pilot Study

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2021
This proposed study aims to evaluate the efficacy of daily Cannabidiol (CBD) Oil Capsules in treating symptoms of DSM-5 anxiety disorders, using a two-arm, 8-week randomized, placebo-controlled trial in adults aged 21-65 years. The study will also evaluate the relationship between inflammation, anxiety and CBD using biological markers as well as examine the neuro-cognitive effects of CBD treatment.
Epistemonikos ID: 0f76853d7452174295ca9edd1e3bf5ad202c3127
First added on: May 21, 2024